Riverstyx Foundation

What Riverstyx Foundation does

Riverstyx Foundation is a small private family foundation established in 2007 and headquartered at 2222 Cleveland Ave #1026 in Santa Rosa, California. The foundation was capitalized from inherited wealth tracing to George D. Smith, co-founder and builder of United Parcel Service. It runs on a lean staff of two Co-Directors - T. Cody Swift and Miriam Volat - supported by an Impact Investment Director/Financial Health Officer, a Chief Health Advisor, an Indigenous Medicine Program Manager, and an external accounting firm. There is no product, no pricing model, and no traditional revenue stream; instead, the foundation disburses grants and makes impact investments drawn from the family endowment.

Its operations are organized into four issue areas: psychospiritual (psychedelic research, end-of-life care), societal (drug policy reform, criminal justice alternatives), bio-cultural (green burial, composting toilets, dark skies), and Indigenous medicine conservation. Grantees and impact-investee partners include Johns Hopkins, NYU, UCSF, MAPS, Heffter Research Institute, Usona Institute, Drug Policy Alliance, NARF, Indigenous Medicine Conservation Fund, Indigenous Peyote Conservation Initiative, Coeio, and Recompose. Since 2008 the foundation has helped fund more than 25 research studies on psilocybin, MDMA, ibogaine, and ayahuasca, and has supported drug-policy ballot initiatives in Colorado, Washington, Oregon, California, Alaska, Maine, and Michigan.

The foundation explicitly does not accept unsolicited proposals, prefers early-stage, stigmatized work, and structures commitments as multi-year, relationship-based engagements with reduced reporting. A 501c4 subsidiary, RiverPsykhe, Inc., absorbs political advocacy, lobbying, and impact-investing activity that a standard 501c3 cannot legally undertake. The organization is not publicly traded, has no parent company, and has no disclosed revenue, headcount, or assets figure.

Name

Riverstyx Foundation

Legal name

Riverstyx Foundation

Website

https://riverstyxfoundation.org

Company type

Private

Founded year

2007

Operating status

Operating

Short description

Riverstyx Foundation is a private family foundation in Santa Rosa, California that makes grants and impact investments to advance psychedelic research, drug policy reform, bio-cultural initiatives, and Indigenous-led plant-medicine conservation, channeling legacy UPS-wealth into early-stage, stigmatized causes via a no-unsolicited-proposals model.

Ownership category

akta.pro rank

Product category

Private Foundation Grant-Making

NAICS

Grantmaking Foundations (813211), Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)

akta.pro primary industry

Community Foundations (BPAGAKAB)

akta.pro secondary industries

Health & Medical Research Grantmaking Foundations (BPAGAKAL), Environmental & Climate Grantmaking Foundations (BPAGAKAM), Social Justice & Human Rights Grantmaking Foundations (BPAGAKAN)

Keywords

• Philanthropic grant-making
• Drug policy reform
• Psychedelic research funding
• Indigenous medicine conservation
• Impact investing

Headquarters

HQ city

Santa Rosa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Others

Revenue model

1. Philanthropic Grant-Making: Riverstyx Foundation operates as a private charitable foundation funded by an inherited family fortune. The foundation makes grants to support psychedelic research, drug policy reform, Indigenous medicine conservation, bio-cultural initiatives (green burial, dark skies, composting toilets), and end-of-life care. It provides catalytic seed funding to fringe areas that have been stigmatized by society and the funding community.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Riverstyx Foundation is a private family foundation that makes grants and impact investments to advance drug policy reform, psychedelic research, and biocultural conservation. The foundation funds clinical research on psilocybin, MDMA, ibogaine, and ayahuasca, supports Indigenous-led sacred plant medicine conservation, backs drug policy reform and criminal justice alternatives, and invests in bio-cultural initiatives such as green burial, dark sky preservation, and composting toilets. It provides catalytic seed funding and multi-year relationship-based capacity building to early-stage projects in stigmatized areas.

Product overview

Riverstyx Foundation is a private philanthropic organization that operates through grant-making, impact investing, and engaged capacity building. It does not offer commercial software products or technology services. Its core activities include funding clinical psychedelic research (psilocybin, MDMA, ibogaine, ayahuasca), supporting drug policy reform and criminal justice alternatives, indigenous medicine conservation efforts, and bio-cultural initiatives such as green burial, dark skies protection, and composting toilet legalization. The foundation has a 501c4 subsidiary called RiverPsykhe Inc that handles political advocacy and impact investments.

Differentiator

Problem solved

Functional benefit

Products and services

• Psychedelic Research Grants Direct grant funding to academic institutions and research organizations conducting clinical trials on psilocybin, MDMA, ibogaine, and ayahuasca for mental health conditions including cancer anxiety, PTSD, depression, addiction, and end-of-life distress. Recipients include Johns Hopkins, NYU, UCSF, MAPS, Usona Institute, and Heffter Research Institute.
• Drug Policy Reform Grants Grants supporting drug decriminalization, criminal justice reform, harm reduction, and alternatives to prohibition. Major grantee partners include Drug Policy Alliance and LEAD National Support Bureau. Funded ballot initiatives in Colorado, Washington, Oregon, California, Alaska, Maine, and Michigan.
• Indigenous Medicine Conservation Grants Grants supporting conservation of five keystone sacred medicines (Ayahuasca, Bufo, Iboga, Peyote, and Mushrooms) and Indigenous-led biocultural conservation efforts. Funded Indigenous Peyote Conservation Initiative (IPCI) and Indigenous Medicine Conservation Fund (IMC Fund). RSF donated 605 acres of conservation land in Mirando City, Texas to IPCI.
• Bio-Cultural Impact Investments

Quantifiable outcome

• Over 25 research studies funded since 2008 on psychedelic compounds
• +2 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

20 partnerships are on record, tiered core, major, impact investment and minor.

• Indigenous Peyote Conservation Initiative (IPCI)coreStrategic or Co-development Partner · 1 January 2017IPCI engages in diverse biocultural strategies for spiritual reconnection and restoration of Peyote, including land access and stewardship, youth education, cultivation and propagation, and regenerative harvest systems. An international collaborative supporting tribes in U.S., Mexico, and Canada. Riverstyx donated 605 acres of conservation land in October 2016.
• MAPS (Multidisciplinary Association for Psychedelic Studies)coreStrategic or Co-development PartnerMAPS is a primary research partner for MDMA-assisted psychotherapy for PTSD. Riverstyx has funded MAPS Phase 2 and Phase 3 clinical trials. RSF policy does not cover university overhead for research projects.
• Heffter Research InstitutecoreStrategic or Co-development PartnerHeffter Research Institute focuses on psilocybin research. Riverstyx has donated estimated $1.5-2 million to support Heffter-sponsored research and advocacy. Heffter is described as keeping 'the flame alive through the darkest years' of psychedelic research.
• Usona InstitutemajorStrategic or Co-development PartnerUsona Institute conducts psilocybin research for major depression. Funded by RSF for multi-site studies.
• Indigenous Medicine Conservation Fund (IMC Fund)coreStrategic or Co-development PartnerA high-impact strategic fund created to ensure Indigenous communities can succeed in biocultural conservation efforts. Addresses the threat and opportunity of the 'psychedelic renaissance' for Indigenous communities. Supports conservation for five keystone medicines: Ayahuasca, Bufo, Iboga, Peyote, and Mushrooms.
• Coeioimpact investmentStrategic or Co-development PartnerImpact investment in green burial technology company developing body composting solutions that encourage the natural process of returning bodies to soil.
• Recomposeimpact investmentStrategic or Co-development PartnerImpact investment in human composting/green burial technology company offering alternative to cremation and traditional burial.
• Occidental Arts and Ecology CentermajorStrategic or Co-development PartnerPartnership to help conduct research and prove viability of composting toilets, ultimately to legalize a technology that can safely process pathogens and return essential nutrients to soil.
• IDA (International Dark-Sky Association)majorStrategic or Co-development PartnerPartnership to reverse light pollution by improving lighting quality and reducing excessive and unnecessary lights. Addresses environmental costs of light pollution and its effects on human health and animal navigation.
• ICEERS (International Center for Ethnobotanical Education, Research and Service)majorStrategic or Co-development PartnerOrganization conducting ayahuasca research for complex grief and bereavement support (2017) and ibogaine research for opiate use disorder (2019).
• NARF (Native American Rights Fund)majorStrategic or Co-development PartnerLegal advocacy organization supporting Indigenous rights related to sacred medicine conservation.
• Drug Policy AlliancemajorStrategic or Co-development PartnerMajor grantee partner working on drug policy reform and alternatives to criminalization.
• LEAD National Support BureaumajorStrategic or Co-development PartnerLaw Enforcement Assisted Diversion program supporting pre-arrest diversion and alternatives to incarceration for non-violent offenders.
• Yoga Behind BarsminorStrategic or Co-development PartnerProgram providing yoga and mindfulness practices to incarcerated individuals.
• University Beyond BarsminorStrategic or Co-development PartnerEducational program providing college courses and opportunities to incarcerated individuals.
• EndWellminorStrategic or Co-development PartnerOrganization working to transform end-of-life care through innovative approaches.
• Women's Visionary CouncilminorStrategic or Co-development PartnerOrganization supporting visionary women in psychedelics and consciousness research.
• SF Zen CenterminorStrategic or Co-development PartnerZen Buddhist practice center involved in psychedelic research and spirituality.
• RiverPsykhe, Inc.coreOthers501c4 tributary of Riverstyx Foundation that funds grants, political and advocacy work, and impact investments related to the mission of Riverstyx.
• Journey Co-LabminorStrategic or Co-development PartnerIn 2020, Riverstyx was asked to assist in developing their reciprocity Trust which would benefit Indigenous communities. RSF provided recommendations to follow UN Nagoya and Biodiversity protocols.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Usona Institute: Usona is a nonprofit medical research organization conducting psilocybin clinical trials for major depressive disorder. Riverstyx has funded Usona's multi-site studies, and both organizations operate as small, mission-driven funders accelerating psychedelic clinical research outside commercial channels.
• Multidisciplinary Association for Psychedelic Studies (MAPS): MAPS is the leading nonprofit advancing MDMA-assisted therapy for PTSD through Phase 2 and Phase 3 clinical trials. Riverstyx has funded MAPS MDMA research and shares the same small-foundation model of catalytic, relationship-based giving to psychedelic science and drug policy reform.
• Chacruna Institute: Chacruna is a nonprofit fostering dialogue about psychedelics, plant medicine, and Indigenous reciprocity. It is a media and convening peer to Riverstyx's grantmaking role, both operating as small private foundations / nonprofits advancing psychedelic and Indigenous medicine discourse outside mainstream academia.
• Beckley Foundation: Beckley Foundation is a UK-based think tank and funder pioneering psychedelic research, drug policy reform, and consciousness studies. Like Riverstyx, it operates as a privately funded, founder-led philanthropic vehicle focused on stigmatized science and policy reform, though with a more international footprint.
• Heffter Research Institute: Heffter is a small nonprofit that funds psilocybin and psychedelic research and is described as having 'kept the flame alive' during the darkest years of the field. Riverstyx has donated $1.5-2M to Heffter over roughly a decade, making it both a grantee and a directly comparable peer in early-stage psychedelic science funding.
• Drug Policy Alliance: Drug Policy Alliance is the leading US nonprofit advocating for drug decriminalization and alternatives to prohibition. Riverstyx is a major grantee partner, and both organizations have been central to state-level reform wins (Oregon Measure 110, Colorado Natural Medicine Health Act) that define the modern reform landscape.
• Indigenous Medicine Conservation Fund (IMC Fund): The IMC Fund is a strategic fund co-founded by Riverstyx in 2022 to direct $20M to Indigenous-led conservation of five keystone sacred medicines. It is both a grantee and an aligned peer — a small, focused, Indigenous-led philanthropic vehicle operating in the same biocultural conservation niche.

Broad incumbents

• Open Society Foundations: Open Society is a global private foundation with major drug policy reform funding through its Public Health Program. It is a broad incumbent operating at vastly greater scale than Riverstyx in the same drug policy reform space, but with a more institutional and less catalytic, founder-driven approach.
• Steven & Alexandra Cohen Foundation: The Cohen Foundation is a large private foundation funding mental health, veterans' services, and biomedical research with significant philanthropic capacity. Comparable as a private foundation active in mental health and biomedical science, but operating at materially larger scale and without Riverstyx's risk-tolerant focus on stigmatized paradigms.

Emerging players

• Bob and Diana Zvara Foundation: A small private family foundation focused on psychedelic research funding with similar scale and approach to Riverstyx. Comparable as a fellow next-generation family philanthropic vehicle entering the same catalytic funding niche, though with a narrower focus on psychedelics and less portfolio diversification across drug policy and biocultural work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights7 records

Customer concentration

• YouTubevimeo.com/user34100899
• Facebookfacebook.com/Riverstyx-Foundation-171849536175894
• LinkedInlinkedin.com/company/riverstyx-foundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Riverstyx Foundation